Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
Listen as FDA reviewers discuss new cancer treatment approvals, emerging safety information, and other topics in cancer drug development.
Listen as FDA reviewers discuss new cancer treatment approvals, emerging safety information, and other topics in cancer drug development.
Agencje rejestrujące leki, takie jak FDA czy EMA, mogą dopuszczać leki w procedurze przyspieszonej lub warunkowo. Bywa, że jeśli lek okaże się nieskuteczny, może zostać…
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Asian Americans, Native Hawaiian, and Other Pacific Islanders
Promoting collaboration in design and analysis of cancer clinical trials
Asian Americans, Native Hawaiian, and Other Pacific Islanders
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) fo
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) fo
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) fo